{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T08:11:37Z","timestamp":1787731897521,"version":"build-2784847793"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,9,4]],"date-time":"2011-09-04T00:00:00Z","timestamp":1315094400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s10875-011-9583-x","type":"journal-article","created":{"date-parts":[[2011,9,6]],"date-time":"2011-09-06T17:12:59Z","timestamp":1315329179000},"page":"946-951","source":"Crossref","is-referenced-by-count":30,"title":["Association of IRF5 Polymorphisms with Susceptibility to Hemophagocytic Lymphohistiocytosis in Children"],"prefix":"10.1007","volume":"31","author":[{"given":"Masakatsu","family":"Yanagimachi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takako","family":"Miyamae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Kadota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Imagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryu","family":"Yanagisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuji","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichi","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumpei","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,9,4]]},"reference":[{"issue":"1","key":"9583_CR1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1586\/eci.09.58","volume":"6","author":"S Gupta","year":"2010","unstructured":"Gupta S, Weitzman S. Primary and secondary hemophagocytic lymphohistiocytosis: clinical features, pathogenesis and therapy. Expert Rev Clin Immunol. 2010;6(1):137\u201354.","journal-title":"Expert Rev Clin Immunol"},{"issue":"5","key":"9583_CR2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.blre.2007.05.001","volume":"21","author":"GE Janka","year":"2007","unstructured":"Janka GE. Hemophagocytic syndromes. Blood Rev. 2007;21(5):245\u201353.","journal-title":"Blood Rev"},{"issue":"4","key":"9583_CR3","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1651-2227.1991.tb11878.x","volume":"80","author":"JI Henter","year":"1991","unstructured":"Henter JI, Elinder G, Soder O, Ost A. Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis. Acta Paediatr Scand. 1991;80(4):428\u201335.","journal-title":"Acta Paediatr Scand"},{"issue":"2","key":"9583_CR4","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124\u201331.","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"9583_CR5","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-10-3413","volume":"104","author":"MB Jordan","year":"2004","unstructured":"Jordan MB, Hildeman D, Kappler J, Marrack P. An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder. Blood. 2004;104(3):735\u201343.","journal-title":"Blood"},{"issue":"7","key":"9583_CR6","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1182\/blood-2006-04-015693","volume":"108","author":"S Marcenaro","year":"2006","unstructured":"Marcenaro S, Gallo F, Martini S, Santoro A, Griffiths GM, Arico M, et al. Analysis of natural killer-cell function in familial hemophagocytic lymphohistiocytosis (FHL): defective CD107a surface expression heralds Munc13-4 defect and discriminates between genetic subtypes of the disease. Blood. 2006;108(7):2316\u201323.","journal-title":"Blood"},{"issue":"8","key":"9583_CR7","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1182\/blood-2001-12-0260","volume":"100","author":"EM Schneider","year":"2002","unstructured":"Schneider EM, Lorenz I, Muller-Rosenberger M, Steinbach G, Kron M, Janka-Schaub GE. Hemophagocytic lymphohistiocytosis is associated with deficiencies of cellular cytolysis but normal expression of transcripts relevant to killer-cell-induced apoptosis. Blood. 2002;100(8):2891\u20138.","journal-title":"Blood"},{"issue":"2","key":"9583_CR8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-2141.1994.tb04905.x","volume":"87","author":"K Akashi","year":"1994","unstructured":"Akashi K, Hayashi S, Gondo H, Mizuno S, Harada M, Tamura K, et al. Involvement of interferon-gamma and macrophage colony-stimulating factor in pathogenesis of haemophagocytic lymphohistiocytosis in adults. Br J Haematol. 1994;87(2):243\u201350.","journal-title":"Br J Haematol"},{"issue":"3","key":"9583_CR9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00043426-199805000-00005","volume":"20","author":"S Imashuku","year":"1998","unstructured":"Imashuku S, Hibi S, Sako M, Ishii T, Kohdera U, Kitazawa K, et al. Heterogeneity of immune markers in hemophagocytic lymphohistiocytosis: comparative study of 9 familial and 14 familial inheritance-unproved cases. J Pediatr Hematol Oncol. 1998;20(3):207\u201314.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"9583_CR10","first-page":"291","volume":"15","author":"S Ohga","year":"1993","unstructured":"Ohga S, Matsuzaki A, Nishizaki M, Nagashima T, Kai T, Suda M, et al. Inflammatory cytokines in virus-associated hemophagocytic syndrome. Interferon-gamma as a sensitive indicator of disease activity. Am J Pediatr Hematol Oncol. 1993;15(3):291\u20138.","journal-title":"Am J Pediatr Hematol Oncol"},{"issue":"2","key":"9583_CR11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00431-006-0258-1","volume":"166","author":"GE Janka","year":"2007","unstructured":"Janka GE. Familial and acquired hemophagocytic lymphohistiocytosis. Eur J Pediatr. 2007;166(2):95\u2013109.","journal-title":"Eur J Pediatr"},{"issue":"4","key":"9583_CR12","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0092-8674(03)00855-9","volume":"115","author":"J Feldmann","year":"2003","unstructured":"Feldmann J, Callebaut I, Raposo G, Certain S, Bacq D, Dumont C, et al. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell. 2003;115(4):461\u201373.","journal-title":"Cell"},{"issue":"1","key":"9583_CR13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1532\/IJH97.07012","volume":"86","author":"E Ishii","year":"2007","unstructured":"Ishii E, Ohga S, Imashuku S, Yasukawa M, Tsuda H, Miura I, et al. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol. 2007;86(1):58\u201365.","journal-title":"Int J Hematol"},{"issue":"5446","key":"9583_CR14","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1126\/science.286.5446.1957","volume":"286","author":"SE Stepp","year":"1999","unstructured":"Stepp SE, Dufourcq-Lagelouse R, Le Deist F, Bhawan S, Certain S, Mathew PA, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 1999;286(5446):1957\u20139.","journal-title":"Science"},{"issue":"6","key":"9583_CR15","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/hmg\/ddi076","volume":"14","author":"U zur Stadt","year":"2005","unstructured":"zur Stadt U, Schmidt S, Kasper B, Beutel K, Diler AS, Henter JI, et al. Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. Hum Mol Genet. 2005;14(6):827\u201334.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"9583_CR16","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ajhg.2009.09.005","volume":"85","author":"U zur Stadt","year":"2009","unstructured":"zur Stadt U, Rohr J, Seifert W, Koch F, Grieve S, Pagel J, et al. Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11. Am J Hum Genet. 2009;85(4):482\u201392.","journal-title":"Am J Hum Genet"},{"issue":"6","key":"9583_CR17","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3201\/eid0606.000608","volume":"6","author":"DN Fisman","year":"2000","unstructured":"Fisman DN. Hemophagocytic syndromes and infection. Emerg Infect Dis. 2000;6(6):601\u20138.","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"9583_CR18","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/S1473-3099(07)70290-6","volume":"7","author":"NG Rouphael","year":"2007","unstructured":"Rouphael NG, Talati NJ, Vaughan C, Cunningham K, Moreira R, Gould C. Infections associated with haemophagocytic syndrome. Lancet Infect Dis. 2007;7(12):814\u201322.","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"9583_CR19","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/01.bor.0000381996.69261.71","volume":"22","author":"AA Grom","year":"2010","unstructured":"Grom AA, Mellins ED. Macrophage activation syndrome: advances towards understanding pathogenesis. Curr Opin Rheumatol. 2010;22(5):561\u20136.","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"9583_CR20","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/BOR.0b013e32825a6a79","volume":"19","author":"A Kelly","year":"2007","unstructured":"Kelly A, Ramanan AV. Recognition and management of macrophage activation syndrome in juvenile arthritis. Curr Opin Rheumatol. 2007;19(5):477\u201381.","journal-title":"Curr Opin Rheumatol"},{"key":"9583_CR21","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3899\/jrheum.100655","volume":"38","author":"M Yanagimachi","year":"2011","unstructured":"Yanagimachi M, Naruto T, Miyamae T, Hara T, Kikuchi M, Hara R, et al. Association of IRF5 polymorphisms with susceptibility to macrophage activation syndrome in patients with juvenile idiopathic arthritis. J Rheumatol. 2011;38:769\u201374.","journal-title":"J Rheumatol"},{"issue":"7030","key":"9583_CR22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nature03308","volume":"434","author":"A Takaoka","year":"2005","unstructured":"Takaoka A, Yanai H, Kondo S, Duncan G, Negishi H, Mizutani T, et al. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature. 2005;434(7030):243\u20139.","journal-title":"Nature"},{"key":"9583_CR23","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1146\/annurev.immunol.19.1.623","volume":"19","author":"T Taniguchi","year":"2001","unstructured":"Taniguchi T, Ogasawara K, Takaoka A, Tanaka N. IRF family of transcription factors as regulators of host defense. Annu Rev Immunol. 2001;19:623\u201355.","journal-title":"Annu Rev Immunol"},{"issue":"5","key":"9583_CR24","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/(SICI)1096-911X(199705)28:5<342::AID-MPO3>3.0.CO;2-H","volume":"28","author":"JI Henter","year":"1997","unstructured":"Henter JI, Arico M, Egeler RM, Elinder G, Favara BE, Filipovich AH, et al. HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH Study Group of the Histiocyte Society. Med Pediatr Oncol. 1997;28(5):342\u20137.","journal-title":"Med Pediatr Oncol"},{"issue":"2","key":"9583_CR25","first-page":"197","volume":"10","author":"M Arico","year":"1996","unstructured":"Arico M, Janka G, Fischer A, Henter JI, Blanche S, Elinder G, et al. Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society. Leukemia. 1996;10(2):197\u2013203.","journal-title":"Leukemia"},{"issue":"2","key":"9583_CR26","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31(2):390\u20132.","journal-title":"J Rheumatol"},{"issue":"5","key":"9583_CR27","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jpeds.2004.12.016","volume":"146","author":"A Ravelli","year":"2005","unstructured":"Ravelli A, Magni-Manzoni S, Pistorio A, Besana C, Foti T, Ruperto N, et al. Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. J Pediatr. 2005;146(5):598\u2013604.","journal-title":"J Pediatr"},{"key":"9583_CR28","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/j.cca.2011.04.036","volume":"412","author":"K Matsuda","year":"2011","unstructured":"Matsuda K, Nakazawa Y, Yanagisawa R, Honda T, Ishii E, Koike K. Detection of T-cell receptor gene rearrangement in children with Epstein\u2013Barr virus-associated hemophagocytic lymphohistiocytosis using the BIOMED-2 multiplex polymerase chain reaction combined with GeneScan analysis. Clin Chim Acta. 2011;412:1554\u20138.","journal-title":"Clin Chim Acta"},{"issue":"5","key":"9583_CR29","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/bioinformatics\/btm025","volume":"23","author":"JR Gonzalez","year":"2007","unstructured":"Gonzalez JR, Armengol L, Sole X, Guino E, Mercader JM, Estivill X, et al. SNPassoc: an R package to perform whole genome association studies. Bioinformatics. 2007;23(5):644\u20135.","journal-title":"Bioinformatics"},{"issue":"1","key":"9583_CR30","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000071811","volume":"55","author":"SL Lake","year":"2003","unstructured":"Lake SL, Lyon H, Tantisira K, Silverman EK, Weiss ST, Laird NM, et al. Estimation and tests of haplotype\u2013environment interaction when linkage phase is ambiguous. Hum Hered. 2003;55(1):56\u201365.","journal-title":"Hum Hered"},{"issue":"3","key":"9583_CR31","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/ard.2007.085704","volume":"68","author":"K Shimane","year":"2009","unstructured":"Shimane K, Kochi Y, Yamada R, Okada Y, Suzuki A, Miyatake A, et al. A single nucleotide polymorphism in the IRF5 promoter region is associated with susceptibility to rheumatoid arthritis in the Japanese population. Ann Rheum Dis. 2009;68(3):377\u201383.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"9583_CR32","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/ng1782","volume":"38","author":"RR Graham","year":"2006","unstructured":"Graham RR, Kozyrev SV, Baechler EC, Reddy MV, Plenge RM, Bauer JW, et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet. 2006;38(5):550\u20135.","journal-title":"Nat Genet"},{"issue":"4","key":"9583_CR33","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1651-2227.1993.tb12699.x","volume":"82","author":"JI Henter","year":"1993","unstructured":"Henter JI, Ehrnst A, Andersson J, Elinder G. Familial hemophagocytic lymphohistiocytosis and viral infections. Acta Paediatr. 1993;82(4):369\u201372.","journal-title":"Acta Paediatr"},{"issue":"16","key":"9583_CR34","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1128\/MCB.22.16.5721-5740.2002","volume":"22","author":"BJ Barnes","year":"2002","unstructured":"Barnes BJ, Kellum MJ, Field AE, Pitha PM. Multiple regulatory domains of IRF-5 control activation, cellular localization, and induction of chemokines that mediate recruitment of T lymphocytes. Mol Cell Biol. 2002;22(16):5721\u201340.","journal-title":"Mol Cell Biol"},{"issue":"5","key":"9583_CR35","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/cmi.2008.44","volume":"5","author":"S Hao","year":"2008","unstructured":"Hao S, Li P, Zhao J, Hu Y, Hou Y. 17beta-estradiol suppresses cytotoxicity and proliferative capacity of murine splenic NK1.1+ cells. Cell Mol Immunol. 2008;5(5):357\u201364.","journal-title":"Cell Mol Immunol"},{"issue":"3","key":"9583_CR36","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/ni.1990","volume":"12","author":"T Krausgruber","year":"2011","unstructured":"Krausgruber T, Blazek K, Smallie T, Alzabin S, Lockstone H, Sahgal N, et al. IRF5 promotes inflammatory macrophage polarization and T(H)1\u2013T(H)17 responses. Nat Immunol. 2011;12(3):231\u20138.","journal-title":"Nat Immunol"},{"issue":"22","key":"9583_CR37","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1182\/blood-2010-01-263020","volume":"115","author":"T Krausgruber","year":"2010","unstructured":"Krausgruber T, Saliba D, Ryzhakov G, Lanfrancotti A, Blazek K, Udalova IA. IRF5 is required for late-phase TNF secretion by human dendritic cells. Blood. 2010;115(22):4421\u201330.","journal-title":"Blood"},{"issue":"4","key":"9583_CR38","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1182\/blood.V98.4.1268","volume":"98","author":"R Sumazaki","year":"2001","unstructured":"Sumazaki R, Kanegane H, Osaki M, Fukushima T, Tsuchida M, Matsukura H, et al. SH2D1A mutations in Japanese males with severe Epstein\u2013Barr virus-associated illnesses. Blood. 2001;98(4):1268\u201370.","journal-title":"Blood"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-011-9583-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-011-9583-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-011-9583-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T04:14:47Z","timestamp":1559276087000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-011-9583-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,4]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["9583"],"URL":"https:\/\/doi.org\/10.1007\/s10875-011-9583-x","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,4]]}}}